South Street Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
South Street Advisors's GILD Position: Q3 2017 in Review
South Street Advisors sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 13,730 shares — an estimated $971K sold.
South Street Advisors first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $16.3M in Q2 2015. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.
- South Street Advisors reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
- South Street Advisors sold 13,730 Gilead Sciences shares in Q3 2017, an estimated $971K.
- South Street Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
- South Street Advisors's Gilead Sciences position peaked at $16.3M in Q2 2015.
- 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.
Based on South Street Advisors's 13F filing for Q3 2017, filed 15 Nov 2017.